B M Fendly

Papers

Total Citations

213

H-Index

About

B M Fendly is a distinguished biochemist and immunologist whose pioneering research has significantly advanced the understanding of antibody-antigen interactions and their therapeutic applications. Fendly’s key contributions center on the structural and functional characterization of monoclonal antibodies, particularly through high-resolution epitope mapping and affinity analysis. Their landmark 1992 study, "High resolution functional analysis of antibody-antigen interactions" (213 citations), established foundational methods for dissecting the molecular basis of antibody specificity, enabling the rational design of more effective immunotherapeutics. This work has had lasting impact on the development of targeted cancer therapies, including the engineering of humanized antibodies that recognize tumor-associated antigens. Fendly’s research has been instrumental in bridging basic immunology and clinical translation, with their methodologies widely adopted in both academic and pharmaceutical settings. Their achievements include collaborations that led to the identification of critical antibody targets, such as HER2, and the optimization of antibody-drug conjugates. With a citation record reflecting enduring influence, Fendly remains a key figure in antibody engineering, inspiring new generations of researchers to explore the precision of immune recognition.